Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Juvenile idiopathic arthritis: Epidemiology and immunopathogenesis

Alexei A Grom, MD
Section Editor
Marisa Klein-Gitelman, MD, MPH
Deputy Editor
Elizabeth TePas, MD, MS


Juvenile idiopathic arthritis (JIA) is a chronic idiopathic inflammatory disorder primarily involving joints. The epidemiology and immunopathogenesis of JIA are reviewed here. Diagnostic criteria and nomenclature of JIA are presented separately. (See "Classification of juvenile arthritis".)

Terminology — The older terms, juvenile rheumatoid arthritis (JRA, used commonly in the United States) and juvenile chronic arthritis (JCA, preferred in Europe), have been replaced by the term JIA. JIA incorporates all of what was called JRA in the past and also includes all other forms of "idiopathic" arthritis in childhood. The term JRA will still be used to describe the general patient population in older studies since JRA is a less inclusive term than JIA (the term JIA will be used for these older studies if a specific subgroup is specified [eg, systemic JIA]). However, most clinicians assume that the results of these earlier studies of JRA are generally applicable to all the categories included in JIA, although the precise numbers will be somewhat different. The JIA nomenclature should be regarded as a "work in progress" that will be refined as the genetic and pathophysiologic understanding of arthritis improves. All of the discussion of epidemiology and pathogenesis that follows is complicated by the fact that JIA is not a single disease, but several different diseases. While there are elements common to all of these diseases, some forms of JIA, such as the human leukocyte antigen (HLA)-B27-associated diseases and systemic JIA, are clearly distinct entities with differing etiologies and pathogenesis.


Overall incidence and prevalence — The lack of standard diagnostic criteria has complicated epidemiologic studies. When the revised American College of Rheumatology (ACR, formerly the ARA) classification criteria were applied to the Rochester Epidemiology Program Project database, an incidence of 13.9 cases of juvenile rheumatoid arthritis (JRA) per 100,000 per year was reported [1]. A follow-up study, utilizing the same database, noted a decrease in incidence over a subsequent decade [2].

The results of other population studies are presented in the table (table 1) [3-7]. In the Rochester study, the prevalence rate for JRA was 94 patients per 100,000 children on January 1, 1980 and 86 on January 1, 1990 [2]. An extrapolation to the entire United States population under 16 years of age in the year 2000 suggests that there must be 70,000 to 100,000 cases of JRA (active and inactive). However, the population in the Rochester study was predominantly Caucasian. The actual prevalence in the total United States population is probably much lower (15,000 to 36,000 in some estimates [8]) because JRA appears to be less common in African-American and Asian populations [9].

Ethnic differences in prevalence have also been noted in other populations. As examples, the prevalence of JRA is less in blacks than in those of Indian ancestry among South African children [10] and is higher in the native population than among Caucasians among Canadian children [11].

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Aug 19, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Towner SR, Michet CJ Jr, O'Fallon WM, Nelson AM. The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. Arthritis Rheum 1983; 26:1208.
  2. Peterson LS, Mason T, Nelson AM, et al. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum 1996; 39:1385.
  3. Laaksonen AL. A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases. Acta Paediatr Scand 1966; :1.
  4. Kunnamo I, Kallio P, Pelkonen P. Incidence of arthritis in urban Finnish children. A prospective study. Arthritis Rheum 1986; 29:1232.
  5. Gäre BA, Fasth A. Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. Pediatrics 1992; 90:950.
  6. Oen K, Fast M, Postl B. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-92: cycles in incidence. J Rheumatol 1995; 22:745.
  7. Symmons DP, Jones M, Osborne J, et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996; 23:1975.
  8. Gewanter HL, Baum J. The frequency of juvenile arthritis. J Rheumatol 1989; 16:556.
  9. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41:778.
  10. Haffejee IE, Raga J, Coovadia HM. Juvenile chronic arthritis in black and Indian South African children. S Afr Med J 1984; 65:510.
  11. Hill R. Juvenile arthritis in various racial groups in British Columbia. Arthritis Rheum 1977; 20:S162 (Abstract).
  12. Graham TB, Glass DN. Juvenile rheumatoid arthritis: ethnic differences in diagnostic types. J Rheumatol 1997; 24:1677.
  13. Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997; 24:1826.
  14. Fujikawa S, Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997; 39:245.
  15. Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975; 18:251.
  16. Schaller JG. Juvenile rheumatoid arthritis: Series 1. Arthritis Rheum 1977; 20:165.
  17. Van Kerckhove C, Balakrishnan K, Levinson JE, et al. HLA and altered sex ratios in juvenile rheumatoid arthritis sibships. Hum Immunol 1988; 22:227.
  18. Schaller J, Kupfer C, Wedgwood RJ. Iridocyclitis in juvenile rheumatoid arthritis. Pediatrics 1969; 44:92.
  19. Cassidy JT, Sullivan DB, Petty RE. Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis. Arthritis Rheum 1977; 20:224.
  20. Aaron S, Fraser PA, Jackson JM, et al. Sex ratio and sibship size in juvenile rheumatoid arthritis kindreds. Arthritis Rheum 1985; 28:753.
  21. Rachelefsky GS, Terasaki PI, Katz R, Stiehm ER. Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med 1974; 290:892.
  22. Schaller JG, Ochs HD, Thomas ED, et al. Histocompatibility antigens in childhood-onset arthritis. J Pediatr 1976; 88:926.
  23. Pritchard MH, Matthews N, Munro J. Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol 1988; 27:176.
  24. Lindsley CB. Seasonal variation in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 1987; 30:838.
  25. Feldman BM, Birdi N, Boone JE, et al. Seasonal onset of systemic-onset juvenile rheumatoid arthritis. J Pediatr 1996; 129:513.
  26. Ansell BM, Bywaters EG, Lawrence JS. Familial aggregation and twin studies in Still's disease. Juvenile chronic polyarthritis. Rheumatology 1969; 2:37.
  27. Rossen RD, Brewer EJ, Sharp RM, et al. Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis. J Clin Invest 1980; 65:629.
  28. Moroldo MB, Tague BL, Shear ES, et al. Juvenile rheumatoid arthritis in affected sibpairs. Arthritis Rheum 1997; 40:1962.
  29. Moroldo MB, Chaudhari M, Shear E, et al. Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. Arthritis Rheum 2004; 50:1928.
  30. Clemens LE, Albert E, Ansell BM. Sibling pairs affected by chronic arthritis of childhood: evidence for a genetic predisposition. J Rheumatol 1985; 12:108.
  31. Rudolf MC, Genel M, Tamborlane WV Jr, Dwyer JM. Juvenile rheumatoid arthritis in children with diabetes mellitus. J Pediatr 1981; 99:519.
  32. Firooz A, Mazhar A, Ahmed AR. Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol 1994; 31:434.
  33. Nepom BS, Glass DN. Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop. J Rheumatol Suppl 1992; 33:70.
  34. Stastny P, Fink CW. Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest 1979; 63:124.
  35. Van Kerckhove C, Melin-Aldana H, Elma MS, et al. A distinct HLA-DRw8 haplotype characterizes patients with juvenile rheumatoid arthritis. Immunogenetics 1990; 32:304.
  36. Glass D, Litvin D, Wallace K, et al. Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest 1980; 66:426.
  37. Howard JF, Sigsbee A, Glass DN. HLA genetics and inherited predisposition to JRA. J Rheumatol 1985; 12:7.
  38. Førre O, Dobloug JH, Høyeraal HM, Thorsby E. HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum 1983; 26:35.
  39. Reekers P, Schretlen ED, van de Putte LB. Increase of HLA-"DRw6" in patients with juvenile chronic arthritis. Tissue Antigens 1983; 22:283.
  40. Hoffman RW, Shaw S, Francis LC, et al. HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29:1057.
  41. Odum N, Morling N, Friis J, et al. Increased frequency of HLA-DPw2 in pauciarticular onset juvenile chronic arthritis. Tissue Antigens 1986; 28:245.
  42. Oen K, Petty RE, Schroeder ML. An association between HLA-A2 and juvenile rheumatoid arthritis in girls. J Rheumatol 1982; 9:916.
  43. Melin-Aldana H, Giannini EH, Taylor J, et al. Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr 1992; 121:56.
  44. van Kerckhove C, Luyrink L, Taylor J, et al. HLA-DQA1*0101 haplotypes and disease outcome in early onset pauciarticular juvenile rheumatoid arthritis. J Rheumatol 1991; 18:874.
  45. Ploski R, Vinje O, Rønningen KS, et al. HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease. Arthritis Rheum 1993; 36:465.
  46. Paul C, Schoenwald U, Truckenbrodt H, et al. HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 1993; 37:442.
  47. Hall PJ, Burman SJ, Laurent MR, et al. Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients. Ann Rheum Dis 1986; 45:464.
  48. Fernandez-Viña MA, Fink CW, Stastny P. HLA antigens in juvenile arthritis. Pauciarticular and polyarticular juvenile arthritis are immunogenetically distinct. Arthritis Rheum 1990; 33:1787.
  49. Nepom BS, Nepom GT, Mickelson E, et al. Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis. J Clin Invest 1984; 74:287.
  50. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205.
  51. Willkens RF, Nepom GT, Marks CR, et al. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum 1991; 34:43.
  52. Murray KJ, Moroldo MB, Donnelly P, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999; 42:1843.
  53. Grom AA, von Knorre C, Murray KJ, et al. T-cell receptor BV6S1 null alleles and HLA-DR1 haplotypes in polyarticular outcome juvenile rheumatoid arthritis. Hum Immunol 1996; 45:152.
  54. McLaughlin JF, Schaller J, Wedgwood RJ. Arthritis and immunodeficiency. J Pediatr 1972; 81:801.
  55. McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995; 38:221.
  56. Date Y, Seki N, Kamizono S, et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 1999; 42:2577.
  57. Maksymowych WP, Gabriel CA, Luyrink L, et al. Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset. Immunogenetics 1992; 35:257.
  58. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102:1369.
  59. Crawley E, Kay R, Sillibourne J, et al. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42:1101.
  60. Sullivan KE, McDonald-McGinn DM, Driscoll DA, et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 1997; 40:430.
  61. Donn RP, Davies EJ, Holt PL, et al. Increased frequency of TAP2B in early onset pauciarticular juvenile chronic arthritis. Ann Rheum Dis 1994; 53:261.
  62. Pryhuber KG, Murray KJ, Donnelly P, et al. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J Rheumatol 1996; 23:747.
  63. Donn RP, Shelley E, Ollier WE, et al. A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44:1782.
  64. Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2402.
  65. Zeggini E, Thomson W, Kwiatkowski D, et al. Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. Arthritis Rheum 2002; 46:3304.
  66. Hinks A, Barton A, John S, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005; 52:1694.
  67. Rosen P, Thompson S, Glass D. Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. Clin Exp Rheumatol 2003; 21:650.
  68. Ogilvie EM, Fife MS, Thompson SD, et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 2003; 48:3202.
  69. Smerdel A, Lie BA, Ploski R, et al. A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:1614.
  70. Thompson SD, Moroldo MB, Guyer L, et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. Arthritis Rheum 2004; 50:2920.
  71. Hinks A, Cobb J, Sudman M, et al. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Ann Rheum Dis 2012; 71:1117.
  72. Thompson SD, Marion MC, Sudman M, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum 2012; 64:2781.
  73. Hinks A, Cobb J, Marion MC, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013; 45:664.
  74. Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 1997; 77:530.
  75. Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49:411.
  76. Inman RD. The role of infection in chronic arthritis. J Rheumatol Suppl 1992; 33:98.
  77. Ogra PL, Chiba Y, Ogra SS, et al. Rubella-virus infection in juvenile rheumatoid arthritis. Lancet 1975; 1:1157.
  78. Linnemann CC Jr, Levinson JE, Buncher CR, Schiff GM. Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis 1975; 34:354.
  79. Al-Nakib W, Majeed HA. Serologic studies on the association of rubella virus infection and juvenile rheumatoid arthritis. Ann Trop Paediatr 1981; 1:93.
  80. Chantler JK, Tingle AJ, Petty RE. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 1985; 313:1117.
  81. Korematsu S, Miyahara H, Kawano T, et al. A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period. Vaccine 2009; 27:5041.
  82. Albani S. Infection and molecular mimicry in autoimmune diseases of childhood. Clin Exp Rheumatol 1994; 12 Suppl 10:S35.
  83. Massa M, Mazzoli F, Pignatti P, et al. Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2721.
  84. Maximov AA, Shaikov AV, Lovell DJ, et al. Chlamydial associated syndrome of arthritis and eye involvement in young children. J Rheumatol 1992; 19:1794.
  85. Lehmann HW, Knöll A, Küster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 2003; 48:1631.
  86. Sieper J, Braun J, Döring E, et al. Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis. Ann Rheum Dis 1992; 51:1208.
  87. Life P, Hassell A, Williams K, et al. Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60. J Rheumatol 1993; 20:1388.
  88. Horton DB, Scott FI, Haynes K, et al. Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics 2015; 136:e333.
  89. Arvonen M, Virta LJ, Pokka T, et al. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections? J Rheumatol 2015; 42:521.
  90. Førre O, Dobloug JH, Natvig JB. Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction. Scand J Immunol 1982; 15:227.
  91. Eberhard BA, Laxer RM, Andersson U, Silverman ED. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 1994; 96:260.
  92. Wynne-Roberts CR, Anderson CH, Turano AM, Baron M. Light- and electron-microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal juvenile synovium. Semin Arthritis Rheum 1978; 7:287.
  93. Wynne-Roberts CR, Anderson C. Light- and electron-microscopic studies of normal juvenile human synovium. Semin Arthritis Rheum 1978; 7:279.
  94. Ziff M. Role of the endothelium in chronic inflammatory synovitis. Arthritis Rheum 1991; 34:1345.
  95. Scola MP, Imagawa T, Boivin GP, et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum 2001; 44:794.
  96. Maeno N, Takei S, Imanaka H, et al. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol 1999; 26:2244.
  97. Bosco MC, Delfino S, Ferlito F, et al. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis. J Rheumatol 2009; 36:1318.
  98. Finnegan S, Clarke S, Gibson D, et al. Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Ann Rheum Dis 2011; 70:1842.
  99. Klareskog L, Forsum U, Scheynius A, et al. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A 1982; 79:3632.
  100. Murray KJ, Luyrink L, Grom AA, et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996; 23:2116.
  101. Lindblad S, Klareskog L, Hedfors E, et al. Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum 1983; 26:1321.
  102. Nunez G, Ball EJ, Stastny P. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens. Hum Immunol 1987; 19:29.
  103. Harding B, Knight SC. The distribution of dendritic cells in the synovial fluids of patients with arthritis. Clin Exp Immunol 1986; 63:594.
  104. Bergroth V, Konttinen YT, Pelkonen P, et al. Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis. Arthritis Rheum 1988; 31:780.
  105. Jalkanen S, Steere AC, Fox RI, Butcher EC. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science 1986; 233:556.
  106. Oen K, Danell G, Stewart S, et al. Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cells. Clin Exp Immunol 1994; 95:415.
  107. Grom AA, Murray KJ, Luyrink L, et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum 1996; 39:1703.
  108. Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, et al. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 1998; 101:1261.
  109. Scola MP, Thompson SD, Brunner HI, et al. Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 2002; 29:369.
  110. Meazza C, Travaglino P, Pignatti P, et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:232.
  111. De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48:1398.
  112. Donn R, Alourfi Z, Zeggini E, et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50:1604.
  113. Odum N, Morling N, Platz P, et al. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis. Ann Rheum Dis 1987; 46:846.
  114. Wedderburn LR, Woo P. Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis. Springer Semin Immunopathol 1999; 21:361.
  115. Issekutz AC, Quinn PJ, Lang B, et al. Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63:3467.
  116. De Maria A, Malnati M, Moretta A, et al. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis. Eur J Immunol 1987; 17:1815.
  117. Førre O, Thoen J, Dobloug JH, et al. Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies. Scand J Immunol 1982; 15:221.
  118. Haufe S, Haug M, Schepp C, et al. Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63:3153.
  119. Gold DP, Offner H, Sun D, et al. Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J Exp Med 1991; 174:1467.
  120. Sioud M, Kjeldsen-Kragh J, Suleyman S, et al. Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells. Eur J Immunol 1992; 22:2413.
  121. Grom AA, Thompson SD, Luyrink L, et al. Dominant T-cell-receptor beta chain variable region V beta 14+ clones in juvenile rheumatoid arthritis. Proc Natl Acad Sci U S A 1993; 90:11104.
  122. Thompson SD, Grom AA, Bailey S, et al. Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis. J Rheumatol 1995; 22:1356.
  123. Wedderburn LR, Maini MK, Patel A, et al. Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood. Int Immunol 1999; 11:535.
  124. Hingorani R, Choi IH, Akolkar P, et al. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol 1993; 151:5762.
  125. Thompson SD, Murray KJ, Grom AA, et al. Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium. Arthritis Rheum 1998; 41:482.
  126. Sioud M, Førre O, Natvig JB. T cell receptor delta diversity of freshly isolated T lymphocytes in rheumatoid synovitis. Eur J Immunol 1991; 21:239.
  127. Kjeldsen-Kragh J, Quayle A, Kalvenes C, et al. T gamma delta cells in juvenile rheumatoid arthritis and rheumatoid arthritis. In the juvenile rheumatoid arthritis synovium the T gamma delta cells express activation antigens and are predominantly V delta 1+, and a significant proportion of these patients have elevated percentages of T gamma delta cells. Scand J Immunol 1990; 32:651.
  128. Shen Y, Li S, Quayle AJ, et al. TCR gamma/delta+ cell subsets in the synovial membranes of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Scand J Immunol 1992; 36:533.
  129. Kjeldsen-Kragh J, Quayle AJ, Vinje O, et al. A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA). Clin Exp Immunol 1993; 91:202.
  130. Born WK, O'Brien RL, Modlin RL. Antigen specificity of gamma delta T lymphocytes. FASEB J 1991; 5:2699.
  131. Söderström K, Halapi E, Nilsson E, et al. Synovial cells responding to a 65-kDa mycobacterial heat shock protein have a high proportion of a TcR gamma delta subtype uncommon in peripheral blood. Scand J Immunol 1990; 32:503.
  132. De Graeff-Meeder ER, van der Zee R, Rijkers GT, et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991; 337:1368.
  133. Gaston JS. Heat shock proteins and arthritis--new readers start here. Autoimmunity 1997; 26:33.
  134. Quayle AJ, Chomarat P, Miossec P, et al. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993; 38:75.
  135. de Kleer IM, Kamphuis SM, Rijkers GT, et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003; 48:2001.
  136. de Kleer IM, Wedderburn LR, Taams LS, et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172:6435.
  137. de Graeff-Meeder ER, van Eden W, Rijkers GT, et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995; 95:934.
  138. Prakken AB, van Eden W, Rijkers GT, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39:1826.
  139. Kamphuis S, Kuis W, de Jager W, et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005; 366:50.
  140. Lehman TJ. Juvenile idiopathic arthritis and HSP60 vaccination: selective down-regulation? Lancet 2005; 366:9.
  141. Murray KJ, Grom AA, Thompson SD, et al. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 1998; 25:1388.
  142. Gattorno M, Facchetti P, Ghiotto F, et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin Exp Immunol 1997; 109:4.
  143. Hunter PJ, Nistala K, Jina N, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010; 62:896.
  144. Patel A, Varsani H, Wederburn LR. The hyporesponsiveness of synovial T cells in juvenile idiopathic arthritis is a property of CD4+CD25+ T cells: evidence for regulatory T cells in juvenile arthritis. Rheumatology (Oxford) 2003; 42:S11 (Abstract).
  145. Wedderburn LR, Robinson N, Patel A, et al. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000; 43:765.
  146. Thompson SD, Luyrink L, Passo MH, et al. Comparison of the beta-chemokine receptors CCR4 and CCR5 expression on T-cells in paired synovial fluid and peripheral blood from juvenile rheumatopid arthritis patients. Arthritis Rheum 1999; 42:S185 (Abstract).
  147. Thompson SD, Luyrink LK, Graham TB, et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol 2001; 166:6899.
  148. Scola MP, Thompson SD, Tsoras M, et al. JRA synovial tissues: Abundance of macrophage products including IL-15 and the chemokines MCP-1, IL-8, and MIP-1alpha. Arthritis Rheum 1999; 42:S394 (Abstract).
  149. Nistala K, Moncrieffe H, Newton KR, et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58:875.
  150. Omoyinmi E, Hamaoui R, Pesenacker A, et al. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 2012; 51:1881.
  151. Dobloug JH, Førre O, Kvien TK, et al. Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis 1982; 41:490.
  152. Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005; 7:R30.
  153. Martini A, Ravelli A, Notarangelo LD, et al. Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis. J Rheumatol 1986; 13:598.
  154. de Benedetti F, Massa M, Robbioni P, et al. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34:1158.
  155. Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005; 201:1479.
  156. Maeno N, Takei S, Nomura Y, et al. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum 2002; 46:2539.
  157. Muzaffer MA, Dayer JM, Feldman BM, et al. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J Rheumatol 2002; 29:1071.
  158. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 1995; 43:227.
  159. Jarvis JN, Jiang K, Frank MB, et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2009; 60:1488.
  160. Frosch M, Vogl T, Seeliger S, et al. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2003; 48:2622.
  161. Foell D, Wittkowski H, Hammerschmidt I, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004; 50:1286.
  162. Tsokos GC, Mavridis A, Inghirami G, et al. Cellular immunity in patients with systemic juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1987; 42:86.
  163. Tsokos GC, Inghirami G, Pillemer SR, et al. Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1988; 47:62.
  164. Morbach H, Wiegering V, Richl P, et al. Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63:3458.
  165. Barnes MG, Grom AA, Thompson SD, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010; 62:3249.
  166. Lipnick RN, Tsokos GC. Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis. Clin Exp Rheumatol 1990; 8:177.
  167. Cassidy JT, Petty RE, Sullivan DB. Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis. J Clin Invest 1973; 52:1931.
  168. Pelkonen P, Savilahti E, Mäkelä AL. Persistent and transient IgA deficiency in juvenile rheumatoid arthritis. Scand J Rheumatol 1983; 12:273.
  169. Allen JC, Kunkel HG. Hidden rheumatoid factors with specificity for native gamma globulins. Arthritis Rheum 1966; 9:758.
  170. Moore T, Dorner RW, Zuckner J. Hidden rheumatoid factor in seronegative juvenile rheumatoid arthritis. Ann Rheum Dis 1974; 33:255.
  171. Moore TL, Zuckner J, Baldassare AR, et al. Complement-fixing hidden rheumatoid factor in juvenile rheumatoid arthritis. Arthritis Rheum 1978; 21:935.
  172. Schaller JG, Johnson GD, Holborow EJ, et al. The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum 1974; 17:409.
  173. Leak AM, Ansell BM, Burman SJ. Antinuclear antibody studies in juvenile chronic arthritis. Arch Dis Child 1986; 61:168.
  174. Rahi AH, Kanski JJ, Fielder A. Immunoglobulins and antinuclear antibodies in aqueous humour from patients with juvenile "rheumatoid" arthritis (Still's disease). Trans Ophthalmol Soc U K 1977; 97:217.
  175. Saulsbury FT. Antibody to ribonucleoprotein in pauciarticular juvenile rheumatoid arthritis. J Rheumatol 1988; 15:295.
  176. Szer W, Sierakowska H, Szer IS. Antinuclear antibody profile in juvenile rheumatoid arthritis. J Rheumatol 1991; 18:401.
  177. Murray KJ, Szer W, Grom AA, et al. Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene. J Rheumatol 1997; 24:560.
  178. Dong X, Wang J, Kabir FN, et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000; 43:85.
  179. Rosenberg AM, Hunt DW, Petty RE. Antibodies to native and denatured type II collagen in children with rheumatic diseases. J Rheumatol 1984; 11:425.
  180. Godfrey WA, Lindsley CB, Cuppage FE. Localization of IgM in plasma cells in the iris of a patient with iridocyclitis and juvenile rheumatoid arthritis. Arthritis Rheum 1981; 24:1195.
  181. Petty RE, Hunt DW, Rollins DF, et al. Immunity to soluble retinal antigen in patients with uveitis accompanying juvenile rheumatoid arthritis. Arthritis Rheum 1987; 30:287.
  182. Uchiyama RC, Osborn TG, Moore TL. Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue. J Rheumatol 1989; 16:1074.
  183. Borel Y, Morimoto C, Cairns L, et al. Anti-T cell antibody in juvenile rheumatoid arthritis. J Rheumatol 1984; 11:56.
  184. Strelkauskas AJ, Schauf V, Wilson BS, et al. Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol 1978; 120:1278.
  185. Barron KS, Lewis DE, Brewer EJ, et al. Cytotoxic anti-T cell antibodies in children with juvenile rheumatoid arthritis. Arthritis Rheum 1984; 27:1272.
  186. Rossen RD, Brewer EJ, Person DA, et al. Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1977; 20:1485.
  187. Balogh Z, Merétey K, Falus A, Bozsóky S. Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis 1980; 39:129.
  188. Moore TL, Sheridan PW, Traycoff RB, et al. Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods. J Rheumatol 1982; 9:395.
  189. Miller JJ 3rd, Olds LC, Huene DB. Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis. Clin Exp Rheumatol 1986; 4:53.
  190. Miller JJ 3rd, Hsu YP, Moss R, et al. The immunologic and clinical associations of the split products of C3 in plasma in juvenile rheumatoid arthritis. Arthritis Rheum 1979; 22:502.
  191. Miller JJ 3rd, Olds LC, Silverman ED, et al. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis. Pediatr Res 1986; 20:1332.
  192. Mollnes TE, Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1986; 29:1359.
  193. Frosch M, Roth J. New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment. Rheumatology (Oxford) 2008; 47:121.